Effect of statin therapy on long-term mortality among patients with myocardial infarction with non-obstructive coronary arteries (MINOCA)

Abstract Background Myocardial infarction with non-obstructive coronary arteries (MINOCA) is associated with the lack of visible atherosclerosis in coronary arteries. Current 2020 ESC Guidelines on the management of acute coronary syndromes state that statins may be beneficial to reducing all-cause...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2023-11, Vol.44 (Supplement_2)
Hauptverfasser: Nowak, K, Stepien, K, Kachnic, N, Horosin, G, Karcinska, A, Walczak, P, Nessler, J, Zalewski, J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Myocardial infarction with non-obstructive coronary arteries (MINOCA) is associated with the lack of visible atherosclerosis in coronary arteries. Current 2020 ESC Guidelines on the management of acute coronary syndromes state that statins may be beneficial to reducing all-cause mortality and major adverse cardiac events (MACE) among MINOCA patients. Although, the existing literature data remains conflicting, recent meta-analysis based on observational studies showed that statin therapy resulted in a reduction of MACE and mortality. Purpose We aimed to assess the effect of statin therapy on long-term mortality among MINOCA patients. Methods 1011 patients were hospitalized between 2012 and 2017 with the diagnosis of MI based on clinical symptoms, electrocardiographic findings, and the evolution of myocardial necrotic biomarkers according to the universal criteria of MI. On admission, coronary angiography was performed in all patients to assess the existence of obstructive lesions in coronary arteries. 72 patients had lesions narrowing a coronary artery by less than 50% and were classified as MINOCA. Results Statins were used by 54 (75.0%) of MINOCA patients. Those treated with statins had a higher prevalence of hypertension (P=0.001), dyslipidemia (P
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehad655.1492